Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Carcinoma, Non-Small-Cell Lung"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Non-Small-Cell+Lung%22
/vufind/Search/Results?lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Non-Small-Cell+Lung%22
Search /vufind/Search2/Results?lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Non-Small-Cell+Lung%22
PubPharm (5.107)
1
Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer : Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Study of Aerosolized Antibiotics and Pembrolizumab in Advanced Non-small Cell Lung Cancer : Phase I Study of Aerosolized Antibiotics and Pembrolizumab in Advanced Non-Small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Testing the Addition of Radiation Therapy to Immunotherapy for Stage IV Non-Small Cell Lung Cancer Patients Who Are PD-L1 Negative : A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy With or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) : A Phase 3 Open-Label, Randomized, Controlled, Global Study of Telisotuzumab Vedotin (ABBV-399) Versus Docetaxel in Subjects With Previously Treated c-Met Overexpressing, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
177Lu-anti-PD-L1 sdAb in Metastatic Non-small Cell Lung Cancer : Phase 0/1 Study of the Safety and Tolerability of 177Lu-RAD204, a Lutetium-177 Radiolabelled Single Domain Antibody Against Programmed Cell Death-Ligand 1 in Patients With Metastatic Non-small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer : Randomized Phase III Study of Combination Osimertinib (AZD9291) and Bevacizumab Versus Osimertinib (AZD9291) Alone as First-Line Treatment for Patients With Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing : A Feasibility Multicenter Phase I Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab : A Phase 1 First in Human Study Evaluating Safety, Pharmacokinetics and Efficacy of ABBV-400 as Monotherapy and in Combination With Bevacizumab in Adult Subjects With Advanced Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors : A PHASE 1, OPEN-LABEL, DOSE ESCALATION AND EXPANSION STUDY OF PF-07265028 AS A SINGLE AGENT AND IN COMBINATION WITH SASANLIMAB EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS, AND ANTI-TUMOR ACTIVITY OF PF-07265028 IN PARTICIPANTS WITH ADVANCED OR METASTATIC SOLID TUMORS
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301) : A Phase III, Randomized, Double-blind Study to Assess the Efficacy and Safety of Lazertinib Versus Gefitinib as the First-line Treatment in Patients With Epidermal Growth Factor Receptor Sensitizing Mutation Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[511]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Carcinoma, Non-Small-Cell Lung
Medienart
5.107
Aufsätze
5.107
E-Artikel
5.107
E-Ressourcen
Zeitschriftentitel
5.107
ClinicalTrials.gov
Thema
5.107
610
Carcinoma, Non-Small-Cell Lung
4.330
Study Type: Interventional
3.578
Lung Neoplasms
1.826
Phase: Phase 2
1.715
Recruitment Status: Completed
1.215
Recruitment Status: Recruiting
802
Phase: Phase 1
719
Study Type: Observational
642
Phase: Phase 3
620
Recruitment Status: Terminated
588
Recruitment Status: Active, not recruiting
435
Carcinoma
418
Recruitment Status: Unknown status
390
Medical Condition: Non-small Cell Lung Cancer
321
Medical Condition: Non Small Cell Lung Cancer
307
Recruitment Status: Not yet recruiting
286
Phase: Phase 1, Phase 2
285
Medical Condition: Non-Small Cell Lung Cancer
266
Medical Condition: Carcinoma, Non-Small-Cell Lung
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3.126
2020-
1.851
2010-2019
130
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
5.107
Englisch
Haven't found what you're looking for?
Wird geladen...